However, most large coffee brands are full of toxins and mold
Source: Jastreboff et al., NEJM 2023 TRIUMPH-4 Phase 3 (68 weeks, 445 participants) Phase 2 Type 2 Diabetes Trial (36 weeks, 281 participants) In the type 2 diabetes population, weight loss was lower than in the obesity trial which is consistent with the pattern seen across all GLP-1 drugs
However, at the 24-week mark, the magnitude of weight loss efficacy does not appear to be negatively affected by the lower baseline, including for Semaglutide and Tirzepatide
Better glycemic control is still the goal in diabetes to prevent microvascular disease
Retatrutide solution, like most authorised incretin-based injectable peptides, is expected to appear as a clear, colourless to slightly yellow liquid when in good condition